Click here to view the United Healthcare (UHC) Medical Policy Updates » April 2024 United…
Anthem Blue Cross Blue Shield December 2017 Medical Policy Updates
Click here to view the Anthem Blue Cross Blue Shield Medical Policy Updates »
New:
Revised:
- DME.00011 Electrical Stimulation as a Treatment for Pain and Related Conditions: Surface and Percutaneous Devices
- DRUG.00017 Hyaluronan Injections in Joints Other Than the Knee
- DRUG.00050 Eculizumab (Soliris®)
- DRUG.00062 Obinutuzumab (Gazyva®)
- DRUG.00071 Pembrolizumab (Keytruda®)
- DRUG.00075 Nivolumab (Opdivo®)
- DRUG.00089 Daclizumab (Zinbryta®)
- DRUG.00109 Durvalumab (Imfinzi™)
- GENE.00011 Gene Expression Profiling for Managing Breast Cancer Treatment
- RAD.00036 MRI of the Breast
- SURG.00028 Surgical and Minimally Invasive Treatments for Benign Prostatic Hyperplasia (BPH) and Other Genitourinary Conditions
- SURG.00145 Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts)
- TRANS.00023 Hematopoietic Stem Cell Transplantation for Multiple Myeloma and Other Plasma Cell Dyscrasias
- TRANS.00024 Hematopoietic Stem Cell Transplantation for Select Leukemias and Myelodysplastic Syndrome
- TRANS.00027 Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors
- TRANS.00028 Hematopoietic Stem Cell Transplantation for Hodgkin Disease and non-Hodgkin Lymphoma
- TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
- TRANS.00030 Hematopoietic Stem Cell Transplantation for Germ Cell Tumors
Archived:
- DME.00004 Electrical Bone Growth Stimulation
- DME.00036 Ultraviolet Light Therapy Delivery Devices for Home Use
- DRUG.00002 Tumor Necrosis Factor Antagonists
- DRUG.00035 Panitumumab (Vectibix®)
- DRUG.00038 Bevacizumab (Avastin®) for Non-Ophthalmologic Indications
- DRUG.00042 Ustekinumab (Stelara®)
- DRUG.00043 Tocilizumab (Actemra®)
- DRUG.00048 Eribulin mesylate (Halaven®)
- DRUG.00051 Ziv-aflibercept (Zaltrap®)
- DRUG.00052 Pertuzumab (Perjeta®)
- DRUG.00055 Denosumab (Prolia®, Xgeva®)
- DRUG.00057 Canakinumab (Ilaris®)
- DRUG.00059 Romiplostim (Nplate®)
- DRUG.00060 Plerixafor Injection (Mozobil™)
- DRUG.00061 Radium Ra 223 Dichloride (Xofigo®)
- DRUG.00066 Antihemophilic Factors and Clotting Factors
- DRUG.00070 Siltuximab (Sylvant®)
- DRUG.00102 Cabazitaxel (Jevtana®)
- GENE.00004 Janus Kinase 2 (JAK2) V617F Gene Mutation Assay
- GENE.00014 Analysis of KRAS Status
- GENE.00019 BRAF Mutation Analysis
- GENE.00032 Molecular Marker Evaluation of Thyroid Nodules
- MED.00032 Treatment of Hyperhidrosis
- MED.00064 Transcatheter Ablation of Arrhythmogenic Foci in the Pulmonary Veins as a Treatment of Atrial Fibrillation or Atrial Flutter (Radiofrequency and Cryoablation)
- MED.00079 Manipulation Under Anesthesia of the Spine and Joints other than the Knee
- MED.00080 Cryopreservation of Oocytes or Ovarian Tissue
- MED.00083 Melanoma Vaccines
- MED.00113 Therapeutic Apheresis
- SURG.00025 Cryosurgical Ablation of Solid Tumors Outside the Liver
- SURG.00050 Radiofrequency Ablation to Treat Tumors Outside the Liver
- SURG.00059 Recombinant Human Bone Morphogenetic Protein
- SURG.00060 Implanted (Epidural and Subcutaneous) Spinal Cord Stimulators (SCS)
- SURG.00064 Cardiac Resynchronization Therapy (CRT) with or without an Implantable Cardioverter Defibrillator (CRT/ICD) for the Treatment of Heart Failure
- SURG.00093 Treatment of Osteochondral Defects
- SURG.00109 Surgical Treatment of Femoracetabular Impingement Syndrome
- TRANS.00015 Meniscal Allograft Transplantation of the Knee
Click here to view the Anthem Blue Cross Blue Shield Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
